When Your Doctor Wants to Increase Your Dose (But You Don't)

The Default Titration Path

Standard GLP-1 prescribing follows a titration schedule: start low, increase gradually, and aim for the maximum approved dose. For semaglutide (Wegovy), that's 2.4 mg weekly. For tirzepatide (Zepbound), it's 15 mg weekly. The titration exists to minimize GI side effects — but the endpoint is always the top dose.

Clinical trials measured efficacy at the maximum dose. The headline weight loss numbers — 15% for semaglutide, 20%+ for tirzepatide — reflect outcomes at those doses. So there's a natural assumption, shared by many providers, that higher is better.

But that assumption doesn't hold for every patient.

What the Evidence Says About Lower Doses

The STEP and SURMOUNT trials did test multiple dose levels, and the data shows a dose-response relationship: higher doses produce more weight loss on average. But the difference between moderate and maximum doses is smaller than many people expect.

For semaglutide, patients on the 1.0 mg dose still achieved meaningful weight loss — approximately 10% in some analyses, compared to 15% at 2.4 mg. For tirzepatide, the 5 mg and 10 mg doses produced 15% and 19.5% weight loss respectively, compared to 20.9% at 15 mg. The jump from 10 mg to 15 mg was less than 1.5 percentage points of additional weight loss.

Meanwhile, side effects — particularly nausea, vomiting, and diarrhea — tend to increase with higher doses. If you're achieving your health goals and tolerating a moderate dose, the marginal benefit of pushing to the max may not justify the additional side effects.

When Staying at a Lower Dose Makes Sense

There's no clinical requirement to reach the maximum dose. A lower dose may be appropriate if you're meeting your weight loss or metabolic goals at a moderate dose, if higher doses cause GI side effects that significantly impact your quality of life, if you're experiencing hair loss, muscle loss, or nutritional deficiencies from too-rapid weight loss, if cost is a factor and a lower dose reduces your out-of-pocket expense, or if you're using a GLP-1 primarily for metabolic benefits (blood sugar, cardiovascular risk) rather than maximum weight loss.

How to Have This Conversation

If your provider recommends increasing your dose and you're hesitant, frame the conversation around your specific goals and response to treatment. Saying "I've lost 25 pounds on this dose and my blood sugar is normal — what's the clinical reason to increase?" is more productive than "I don't want a higher dose."

Ask your provider to explain the expected additional benefit of the higher dose versus the additional side effect risk. Ask whether your current labs (A1C, lipids, liver enzymes) support staying where you are. And ask what metrics would indicate that a dose increase is clinically warranted versus merely following the default protocol.

A good provider will individualize the decision. The goal of GLP-1 therapy is optimal health — not necessarily the maximum dose.

The Flip Side: When You Should Go Higher

There are legitimate clinical reasons to titrate up. If you've hit a true weight plateau well short of your health goals, if your blood sugar remains above target despite medication, or if your provider identifies specific metabolic markers that haven't improved enough, a dose increase may be warranted.

The decision should be collaborative. Your provider brings clinical expertise; you bring lived experience of how the medication affects your daily life. Both matter.

The Bottom Line

GLP-1 dosing should be personalized, not automated. The maximum dose isn't inherently the right dose for every patient. If you're responding well at a moderate dose with good tolerability, that may be your optimal treatment — and you have every right to advocate for it.